Bill Few Associates
INMB icon

Bill Few Associates’s INmune Bio INMB Stock Holding History

Bill Few Associates’s Portfolio INMB Stock Details INMB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$20.8K Buy
+10,675
New +$22K ﹤0.01% 234

Other funds holding INMB

Abel Hall LLC
Abel Hall LLC Baton Rouge, Louisiana $556M AUM 43.18% 1-Year Est. Return
Davenport & Co
Davenport & Co Richmond, Virginia $19.9B AUM 12.67% 1-Year Est. Return
SBI Securities
SBI Securities Tokyo, Japan $4.38B AUM 56.37% 1-Year Est. Return
GAMMA Investing
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
IFP Advisors
IFP Advisors Tampa, Florida $5.86B AUM 20.09% 1-Year Est. Return
Essential Partners
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

Bill Few Associates's INMB Position: Q3 2026 in Review

Bill Few Associates opened a new position in INmune Bio (INMB) in Q3 2026: 10,675 shares worth $20.8K. The stake represents ﹤0.01% of the portfolio and ranks #234 among its holdings.

7 funds tracked by Wall St. Rank hold INMB as of Q3 2026.

  • Bill Few Associates held 10,675 shares of INmune Bio worth $20.8K as of Q3 2026.
  • INmune Bio was a new Bill Few Associates position in Q3 2026.
  • INmune Bio made up ﹤0.01% of Bill Few Associates's portfolio in Q3 2026, its #234 holding.
  • 7 funds tracked by Wall St. Rank held INmune Bio as of Q3 2026.

Based on Bill Few Associates's 13F filing for Q3 2026, filed 9 Oct 2026.